Charles Fitzgerald Purchases 14,000 Shares of Global Medical REIT (NYSE:XRN) Stock

Global Medical REIT Inc. (NYSE:XRN) Director Charles Fitzgerald bought 14,000 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The shares were purchased at an average price of $35.78 per share, with a total value of $500,920.00. Following the acquisition, the director directly owned 138,893 shares in the company, valued at approximately $4,969,591.54. This trade represents a 11.21% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Charles Fitzgerald also recently made the following trade(s):

• On Monday, August 10th, Charles Fitzgerald bought 27,600 shares of Global Medical REIT stock. The shares were acquired at an average cost of $35.94 per share, with a total value of $991,944.00.

Global Medical REIT Trading Up 1.9%

NYSE XRN opened at $37.28 on Friday. Global Medical REIT Inc. has a one year low of $29.05 and a one year high of $39.93. The company’s 50 day moving average price is $36.62 and its 200 day moving average price is $35.81. The company has a debt-to-equity ratio of 1.37, a quick ratio of 0.68 and a current ratio of 0.59. The firm has a market capitalization of $493.59 million, a price-to-earnings ratio of 10.02 and a beta of 1.09.

Global Medical REIT (NYSE:XRN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $4.78 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $3.95. Global Medical REIT had a net margin of 36.82% and a return on equity of 13.31%. The firm had revenue of $39.75 million for the quarter. On average, sell-side analysts predict that Global Medical REIT Inc. will post 2.89 EPS for the current year.

Institutional Trading of Global Medical REIT

Hedge funds have recently made changes to their positions in the company. Invesco Ltd. lifted its position in shares of Global Medical REIT by 4.2% during the fourth quarter. Invesco Ltd. now owns 310,432 shares of the company’s stock worth $10,474,000 after purchasing an additional 12,471 shares in the last quarter. Mackenzie Financial Corp purchased a new position in shares of Global Medical REIT in the fourth quarter valued at $563,000. XTX Topco Ltd acquired a new stake in Global Medical REIT during the 4th quarter valued at $515,000. Tudor Investment Corp ET AL acquired a new stake in Global Medical REIT during the 4th quarter valued at $930,000. Finally, Clifford Capital Partners LLC increased its stake in Global Medical REIT by 31.3% during the 4th quarter. Clifford Capital Partners LLC now owns 14,694 shares of the company’s stock worth $496,000 after buying an additional 3,504 shares during the period. Hedge funds and other institutional investors own 57.52% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on XRN shares. Weiss Ratings lowered shares of Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, July 30th. Wall Street Zen downgraded Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Zacks Research raised Global Medical REIT to a “hold” rating in a research report on Wednesday, July 22nd. Compass Point restated a “neutral” rating and set a $38.00 price objective (down from $50.00) on shares of Global Medical REIT in a research note on Thursday, May 7th. Finally, Citizens Jmp upped their target price on Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a research report on Tuesday, May 26th. Two research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Global Medical REIT has a consensus rating of “Hold” and an average price target of $40.25.

Global Medical REIT News Summary

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: CEO Mark Okey Decker, Jr. bought 8,000 shares at $35.88 and an additional 6,875 shares at $35.92, while COO Aaron Robert Roseth purchased 13,500 shares at $36.73. Director Charles Fitzgerald also acquired 14,000 shares at $35.78. The reported purchases represent more than $1.5 million of direct insider buying, a potentially bullish signal. Global Medical REIT CEO Purchases Shares
• Positive Sentiment: Global Medical REIT’s latest quarterly results significantly exceeded expectations: earnings per share were $4.78 versus the $0.83 consensus estimate, with revenue of $39.75 million. The company also reported a 36.82% net margin and 13.74% return on equity, providing fundamental support for investor interest.
• Neutral Sentiment: Analyst opinion remains mixed, with two Buy ratings, five Holds and one Sell. The average price target is $40.25, above the recent trading range, but Compass Point maintains a $38 target while Citizens JMP has a $42 target. The overall consensus rating is Hold.
• Neutral Sentiment: Institutional investors own approximately 57.52% of XRN. Recent filings show several funds increasing positions, although the disclosed transactions are not necessarily a near-term catalyst.
• Neutral Sentiment: Coverage also discusses Global Medical REIT’s rebranding and transition to Chiron Real Estate, which may create uncertainty about the company’s identity and strategic direction. Chiron Real Estate rebrand article
• Negative Sentiment: The REIT remains relatively leveraged, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68. High debt and limited liquidity could weigh on valuation if interest rates stay elevated or healthcare property conditions weaken.

About Global Medical REIT

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.